XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Equity - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock
Common stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
 [1]
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
 [1]
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance (in shares) at Dec. 31, 2021       50,000,000 50,000,000                    
Beginning balance at Dec. 31, 2021 $ 1,531 $ (97) $ 1,434 $ 0 $ 0 $ 2,439 $ (131) $ 2,308 $ (790) $ (790) $ 397 $ 34 $ 431 $ (515) $ (515)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common Stock repurchased (147)               (147)            
Stock-based compensation — restricted shares issued 0         1     (1)            
Shares granted 7               7            
Net income 482 [2]                   482        
Other comprehensive income (loss) 51                         51  
Ending balance (in shares) at Dec. 31, 2022       50,000,000 50,000,000                    
Ending balance at Dec. 31, 2022 1,827 $ 1 $ 1,828 $ 0 $ 0 2,309   $ 2,309 (931) $ (931) 913 $ 1 $ 914 (464) $ (464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common Stock repurchased (356)               (356)            
Capped call settlement 0         412     (412)            
Stock-based compensation — restricted shares issued 1         1                  
Conversion of 2028 Convertible Notes 437         (952)     1,389            
Net income 987 [2]                   987        
Other comprehensive income (loss) $ 174                         174  
Ending balance (in shares) at Dec. 31, 2023 50,697,442     50,000,000                      
Ending balance at Dec. 31, 2023 $ 3,071 [3]     $ 0   1,770     (310)   1,901     (290)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common Stock repurchased (1)               (1)            
Net income 1,911                   1,911        
Other comprehensive income (loss) $ (630)                         (630)  
Ending balance (in shares) at Dec. 31, 2024 50,697,375     50,000,000                      
Ending balance at Dec. 31, 2024 $ 4,351     $ 0   $ 1,770     $ (311)   $ 3,812     $ (920)  
[1] As of December 31, 2024 the Company held 225,474 shares as treasury stock.
[2] Recast for consistency with the current presentation due to the change in the presentation of certain financial results. Please refer to Note 2 – Summary of significant accounting policies - Change in the presentation of certain financial results and reclassification of prior years results to our audited consolidated financial statements for further details.
[3] Recast for consistency due to the adoption of Staff Accounting Bulletin No. 122. Please refer to Note 2 – Summary of significant accounting policies - Recently Adopted Accounting Standards to our audited consolidated financial statements for further details.